Copyright
©The Author(s) 2024.
World J Nephrol. Dec 25, 2024; 13(4): 98969
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.98969
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.98969
Figure 1 Kaplan–Meier survival analysis of primary Ig-associated mesangiocapillary glomerulonephritis patients.
A: Development of renal endpoint; B: Follow-up stratified by requirement of kidney replacement therapy (KRT) on presentation. Ig-MCGN: Immunoglobulin-associated mesangiocapillary glomerulonephritis.
- Citation: Elahi T, Ahmed S, Mubarak M. Short-term renal and patient outcomes of primary immunoglobulin-associated mesangiocapillary glomerulonephritis: Insights from a developing country. World J Nephrol 2024; 13(4): 98969
- URL: https://www.wjgnet.com/2220-6124/full/v13/i4/98969.htm
- DOI: https://dx.doi.org/10.5527/wjn.v13.i4.98969